Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma

NCT03177668 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Pleural Mesothelioma

Interventions

DRUG: YS110

Sponsor

Kissei Pharmaceutical Co., Ltd.